Feature|Articles|May 5, 2025

AUA 2025 recap: Urologic oncology trials in progress

Fact checked by: Benjamin P. Saylor, Strategic Content Lead

Take a look through some of the notable studies that were spotlighted during this year’s meeting.

The 2025 American Urological Association (AUA) Annual Meeting in Las Vegas, Nevada featured several sessions on ongoing clinical trials in urologic oncology. These spanned several up-and-coming agents in the non–muscle invasive bladder cancer (NMIBC) space, as well as potential practice-informing studies in both prostate and kidney cancer.